Enbridge Inc (ENB)vsNovo Nordisk A/S (NVO)
ENB
Enbridge Inc
$54.48
+0.07%
ENERGY · Cap: $116.68B
NVO
Novo Nordisk A/S
$36.33
-1.52%
HEALTHCARE · Cap: $165.02B
Smart Verdict
WallStSmart Research — data-driven comparison
Novo Nordisk A/S generates 374% more annual revenue ($309.06B vs $65.19B). NVO leads profitability with a 33.1% profit margin vs 11.5%. ENB appears more attractively valued with a PEG of 1.82. ENB earns a higher WallStSmart Score of 67/100 (B-).
ENB
Strong Buy67
out of 100
Grade: B-
NVO
Buy55
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+53.1%
Fair Value
$109.98
Current Price
$54.48
$55.50 discount
Margin of Safety
-59.4%
Fair Value
$24.21
Current Price
$36.33
$12.12 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
Large-cap with strong market position
Reasonable price relative to book value
Attractively priced relative to earnings
Every $100 of equity generates 61 in profit
Keeps 33 of every $100 in revenue as profit
Strong operational efficiency at 44.5%
Large-cap with strong market position
Areas to Watch
Expensive relative to growth rate
2.9% earnings growth
Weak financial health signals
Distress zone — elevated risk
Weak financial health signals
Expensive relative to growth rate
Revenue declined 7.6%
Earnings declined 4.7%
Comparative Analysis Report
WallStSmart ResearchBull Case : ENB
The strongest argument for ENB centers on Debt/Equity, Market Cap, Price/Book.
Bull Case : NVO
The strongest argument for NVO centers on P/E Ratio, Return on Equity, Profit Margin. Profitability is solid with margins at 33.1% and operating margin at 44.5%.
Bear Case : ENB
The primary concerns for ENB are PEG Ratio, EPS Growth, Piotroski F-Score.
Bear Case : NVO
The primary concerns for NVO are Piotroski F-Score, PEG Ratio, Revenue Growth.
Key Dynamics to Monitor
ENB profiles as a value stock while NVO is a declining play — different risk/reward profiles.
ENB carries more volatility with a beta of 0.86 — expect wider price swings.
ENB is growing revenue faster at 5.9% — sustainability is the question.
ENB generates stronger free cash flow (105M), providing more financial flexibility.
Bottom Line
ENB scores higher overall (67/100 vs 55/100). Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Enbridge Inc
ENERGY · OIL & GAS MIDSTREAM · USA
Enbridge Inc. is an energy infrastructure company. The company is headquartered in Calgary, Canada.
Novo Nordisk A/S
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Novo Nordisk A / S, a healthcare company, is dedicated to the research, development, manufacture and marketing of pharmaceutical products globally. The company is headquartered in Bagsvaerd, Denmark.
Compare with Other OIL & GAS MIDSTREAM Stocks
Want to dig deeper into these stocks?